Skip to main content
18.97.14.83

Reactor design and selection for effective continuous manufacturing of pharmaceuticals

By Hu, Chuntian

Published on

Abstract

Pharmaceutical production remains one of the last industries that predominantly uses batch processes, which are inefficient and can cause drug shortages due to the long lead times or quality defects. Consequently, pharmaceutical companies are transitioning away from outdated batch lines, in large part motivated by the many advantages of continuous manufacturing (e.g., low cost, quality assurance, shortened lead time). As chemical reactions are fundamental to any drug production process, the selection of reactor and its design are critical to enhanced performance such as improved selectivity and yield. In this article, relevant theories, and models, as well as their required input data are summarized to assist the reader in these tasks, focusing on continuous reactions. Selected examples that describe the application of plug flow reactors (PFRs) and continuous-stirred tank reactors (CSTRs)-in-series within the pharmaceutical industry are provided. Process analytical technologies (PATs), which are important tools that provide real-time in-line continuous monitoring of reactions, are recommended to be considered during the reactor design process (e.g., port design for the PAT probe). Finally, other important points, such as density change caused by thermal expansion or solid precipitation, clogging/fouling, and scaling-up, are discussed.

Journal

Journal of Flow Chemistry. Volume 11, 2021, 243-263

DOI

10.1007/s41981-021-00164-3

Type of publication

Peer-reviewed journal

Affiliations

  • CONTINUUS Pharmaceuticals, Woburn

Article Classification

Review article

Classification Areas

  • PAT
  • API

Tags